AIC
IMDX

AWM Investment Company’s Insight Molecular Diagnostics IMDX Stock Holding History

AWM Investment Company’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.7M Buy
2,836,692
+30,436
+1% +$150K 1.45% 22
2026
Q1 		$9.2M Sell
2,806,256
-7,974
-0.3% -$46.3K 1.02% 29
2025
Q4 		$21.1M Sell
2,814,230
-8,300
-0.3% -$46.8K 2.04% 18
2025
Q3 		$9.37M Hold
2,822,530
– – 0.88% 42
2025
Q2 		$8.52M Hold
2,822,530
– – 0.96% 38
2025
Q1 		$8.64M Buy
2,822,530
+2,046,726
+264% +$5.53M 1.19% 34
2024
Q4 		$1.85M Sell
775,804
-321,371
-29% -$873K 0.22% 68
2024
Q3 		$3.13M Hold
1,097,175
– – 0.38% 60
2024
Q2 		$3.24M Buy
1,097,175
+342,889
+45% +$942K 0.44% 60
2024
Q1 		$2.21M Hold
754,286
– – 0.29% 70
2023
Q4 		$1.87M Buy
754,286
+35,004
+5% +$108K 0.25% 76
2023
Q3 		$2.36M Buy
719,282
+9,999
+1% +$37.2K 0.35% 64
2023
Q2 		$3.26M Buy
709,283
+370,630
+109% +$1.87M 0.44% 55
2023
Q1 		$2.4M Sell
338,653
-24,058
-7% -$179K 0.32% 68
2022
Q4 		$2.33M Sell
362,711
-24,617
-6% -$271K 0.34% 57
2022
Q3 		$5.66M Hold
387,328
– – 0.86% 33
2022
Q2 		$6.97M Buy
387,328
+375,235
+3,103% +$8.53M 1.1% 32
2022
Q1 		$360K Hold
12,093
– – 0.05% 110
2021
Q4 		$525K Sell
12,093
-23,757
-66% -$1.37M 0.05% 112
2021
Q3 		$2.55M Buy
35,850
+2,500
+7% +$230K 0.25% 83
2021
Q2 		$3.83M Sell
33,350
-4,150
-11% -$405K 0.38% 73
2021
Q1 		$3.89M Buy
+37,500
New +$3.56M 0.43% 68

Other funds holding IMDX

BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
FOR
Family Office Research Bethesda, Maryland $267M AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AWM Investment Company's IMDX Position: Q2 2026 in Review

AWM Investment Company increased its Insight Molecular Diagnostics (IMDX) stake by 1.1% in Q2 2026, buying an estimated $150K and bringing the position to 2,836,692 shares worth $16.7M. The position accounts for 1.45% of the portfolio, ranked #22.

AWM Investment Company first reported a position in IMDX in Q1 2021 and has held it in 22 quarters since. The position peaked at $21.1M in Q4 2025. 40 funds tracked by Wall St. Rank hold IMDX as of Q2 2026.

  • AWM Investment Company held 2,836,692 shares of Insight Molecular Diagnostics worth $16.7M as of Q2 2026.
  • AWM Investment Company bought 30,436 Insight Molecular Diagnostics shares in Q2 2026, an estimated $150K.
  • Insight Molecular Diagnostics made up 1.45% of AWM Investment Company's portfolio in Q2 2026, its #22 holding.
  • AWM Investment Company first reported a position in Insight Molecular Diagnostics in Q1 2021 and has held it in 22 quarters since.
  • AWM Investment Company's Insight Molecular Diagnostics position peaked at $21.1M in Q4 2025.
  • 40 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q2 2026.

Based on AWM Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.